Randall Yatscoff
Plus aucun poste en cours
Profil
Randall Yatscoff is President and Chief Executive Officer of Isotechnika, Inc. and has been a Director and an Officer since 1996.
Dr. Yatscoff has over 17 years of experience as a Director of hospital-based diagnostic laboratories.
He was a Professor and Director of Medical Biochemistry at the Department of Laboratory Medicine and Pathology at the University of Alberta and the University of Alberta Hospitals.
Dr. Yatscoff was a Professor in the Department of Surgery, the Divisions of Cardiothoracic Surgery and Experimental Surgery at the University of Alberta and the University of Alberta Hospitals.
He received a PhD in Biochemistry from McMaster University in 1980 and completed his fellowship in Clinical Biochemistry in 1984.
Anciens postes connus de Randall Yatscoff
| Sociétés | Poste | Fin |
|---|---|---|
Enterprise Capital Corp.
 Enterprise Capital Corp. Financial ConglomeratesFinance Enterprise Capital Corp. operates as a development stage company. It intends to identify and evaluate business and assets to complete a qualifying transaction. It is headquartered in Edmonton, Canada. | Directeur Financier/CFO | 08/04/2010 |
Isotechnika, Inc.
 Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | President | 01/10/2007 |
Formation de Randall Yatscoff
| McMaster University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Isotechnika, Inc.
Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | Health Technology |
Enterprise Capital Corp.
Enterprise Capital Corp. Financial ConglomeratesFinance Enterprise Capital Corp. operates as a development stage company. It intends to identify and evaluate business and assets to complete a qualifying transaction. It is headquartered in Edmonton, Canada. | Finance |
